Glancy Binkow & Goldberg LLP Announces Investigation of Arch Chemicals, Inc.
12 Luglio 2011 - 1:45AM
Business Wire
Glancy Binkow & Goldberg LLP announces that it is
investigating potential claims against the board of directors of
Arch Chemicals, Inc. (“Arch Chemicals” or the “Company”) (NYSE:ARJ)
related to the Company’s agreement to be acquired by Lonza Ltd. in
a proposed transaction where Arch Chemicals shareholders will
receive $47.20 per share in cash for each share they own of the
Company’s common stock. The transaction is valued at approximately
$1.2 billion.
The investigation concerns whether the board of directors of
Arch Chemicals breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into the proposed transaction, and whether the Company has
disclosed all material information to shareholders about the
transaction. Arch Chemicals has experienced recent positive
financial results. Additionally, at least one analyst has set a
target price of $47.00 per share, virtually nullifying any premium
that Arch Chemicals shareholders would receive under the
transaction.
If you are a shareholder of Arch Chemicals, if you have
information or would like to learn more about these claims, or if
you wish to discuss these matters or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Louis Boyarsky, Esquire, Glancy Binkow
& Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los
Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at
(888) 773-9224 or by email to shareholders@glancylaw.com.
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Arch Chemicals (Borsa di New York (NYSE)): 0 articoli recenti
Più Glancy Binkow & Goldberg LLP Articoli Notizie